Skip to main content

Table 3 Linear regressions showing adiposity in relation to blood pressure

From: Is vulnerability to cardiometabolic disease in Indians mediated by abdominal adiposity or higher body adiposity

 

APCAPS

IMS

 

Age and sex adjusted Coefficient (95% CI)

P-value

Age and sex adjusted Coefficient (95% CI)

P-value

SBP

N = 1,371

 

N = 644

 

DXA Total fat (g)

1.41 (0.91, 1.91)

<0.001

1.01 (-0.23, 2.24)

0.11

BMI kg/m2

2.14 (1.57, 2.72)

<0.001

1.59 (0.35, 2.83)

0.006

Body fat % (skinfolds)

1.72 (1.18, 2.26)

<0.001

1.01 (-0.36, 2.40)

0.15

DXA L1L4 fat (g)

1.75 (1.24, 2.25)

<0.001

1.69 (0.48, 2.89)

0.006

WHR

0.86 (0.24, 1.48)

0.007

2.66 (1.45, 3.88)

<0.001

Waist circumference

2.16 (1.58, 2.74)

<0.001

2.33 (1.08, 3.58)

<0.001

DBP

N = 1,371

 

N = 644

 

DXA Total fat (g)

2.71 (2.31, 3.11)

<0.001

2.42 (1.62, 3.22)

<0.001

BMI kg/m2

2.58 (2.18, 2.97)

<0.001

2.52 (1.72, 3.34)

<0.001

Body fat % (skinfolds)

2.65 (2.23, 3.07)

<0.001

2.09 (1.18, 3.00)

<0.001

DXA L1L4 fat (g)

2.82 (2.41, 3.23)

<0.001

2.82 (2.03, 3.60)

<0.001

WHR

1.05 (0.60, 1.52)

<0.001

2.18 (1.36, 3.00)

<0.001

Waist circumference

2.67 (2.27, 3.07)

<0.001

2.91 (2.09, 3.74)

<0.001

  1. Values Are Relative Increases in Biomarkers Per 1 Standard Deviation in Adiposity Measure.
  2. DXA measures additionally adjusted for DXA machine, DXA total fat (grams) and DXA L1L4 fat (grams) additionally adjusted for height.